Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel O Stram

Showing results (211-220 of 294) with videos related to

Pageof 30
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumSara Lindström, Jing Ma, David Altshuler, et al.
Obstetrics and Gynecology|April 8, 2016
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma RiskAlice W Lee, Roberta B Ness, Lynda D Roman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 28, 2014
Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3)Alison M Mondul, Irene M Shui, Kai Yu, et al.
Cancer Research|April 6, 2007
A common 8q24 variant in prostate and breast cancer from a large nested case-control studyFredrick R Schumacher, Heather Spencer Feigelson, David G Cox, et al.
Human Molecular Genetics|July 4, 2009
Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3)Jiyoung Ahn, Fredrick R Schumacher, Sonja I Berndt, et al.
Journal of Medical Genetics|September 14, 2012
Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor statusAnika Hüsing, Federico Canzian, Lars Beckmann, et al.
Human Molecular Genetics|May 24, 2014
A comprehensive examination of breast cancer risk loci in African American womenYe Feng, Daniel O Stram, Suhn Kyong Rhie, et al.
Plos One|March 11, 2011
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3Sara Lindstrom, Fredrick Schumacher, Afshan Siddiq, et al.
Journal of the National Cancer Institute|July 28, 2011
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortiumDaniele Campa, Rudolf Kaaks, Loïc Le Marchand, et al.
Human Molecular Genetics|March 23, 2011
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskCeleste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, et al.
Pageof 30

Showing results (211-220 of 294) with videos related to

Sort By:
Pageof 30
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumSara Lindström, Jing Ma, David Altshuler, et al.
Obstetrics and Gynecology|April 8, 2016
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma RiskAlice W Lee, Roberta B Ness, Lynda D Roman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 28, 2014
Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3)Alison M Mondul, Irene M Shui, Kai Yu, et al.
Cancer Research|April 6, 2007
A common 8q24 variant in prostate and breast cancer from a large nested case-control studyFredrick R Schumacher, Heather Spencer Feigelson, David G Cox, et al.
Human Molecular Genetics|July 4, 2009
Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3)Jiyoung Ahn, Fredrick R Schumacher, Sonja I Berndt, et al.
Journal of Medical Genetics|September 14, 2012
Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor statusAnika Hüsing, Federico Canzian, Lars Beckmann, et al.
Human Molecular Genetics|May 24, 2014
A comprehensive examination of breast cancer risk loci in African American womenYe Feng, Daniel O Stram, Suhn Kyong Rhie, et al.
Plos One|March 11, 2011
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3Sara Lindstrom, Fredrick Schumacher, Afshan Siddiq, et al.
Journal of the National Cancer Institute|July 28, 2011
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortiumDaniele Campa, Rudolf Kaaks, Loïc Le Marchand, et al.
Human Molecular Genetics|March 23, 2011
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskCeleste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, et al.
Pageof 30